Historical record - last NADAC effective date: 12/23/2020
Product Information
DEMECLOCYCLINE 300 MG TABLET is a generic product labeled by PuraCap Laboratories LLC, priced at $9.9346 per EA under NDC 24658071148. Its NADAC has been published 104 times since Jan 23, 2019.
FDA first approved this application on Aug 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
PuraCap Laboratories LLCNDC
24658071148
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/23/2020
Active Ingredients
DEMECLOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065447FDA Approved
8/18/2015
TE Code
AB
On Market Since
10/7/2017
Pharmacological Classes
Price Statistics
The NADAC for DEMECLOCYCLINE 300 MG TABLET has been published 104 times since Jan 23, 2019, and over the history we have for it it has risen 86.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.9346 per EA |
|---|---|
| All-time high | $9.9346 (Dec 15, 2021) |
| All-time low | $5.3142 (Jan 23, 2019) |
| Median price | $7.6244 |
| Average price | $7.6244 |
| Largest weekly change | +86.9% (Dec 23, 2020) |
| Weeks tracked | 104 |
| Tracking since | Jan 23, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
+86.9%
Last surveyed Dec 15, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEMECLOCYCLINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEMECLOCYCLINE 300 MG TABLET, manufactured by PuraCap Laboratories LLC, is $9.9346 per EA (NDC 24658071148), effective Dec 15, 2021.
How has the price of DEMECLOCYCLINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEMECLOCYCLINE 300 MG TABLET has risen 86.9%. It has been tracked across 104 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for DEMECLOCYCLINE 300 MG TABLET?
Since Jan 23, 2019, the NADAC for DEMECLOCYCLINE 300 MG TABLET has ranged from a low of $5.3142 (Jan 23, 2019) to a high of $9.9346 (Dec 15, 2021), with a median of $7.6244 per EA.
Are there cheaper alternatives to DEMECLOCYCLINE 300 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEMECLOCYCLINE 300 MG TABLET, is $3.0577 per EA — about 69% below DEMECLOCYCLINE 300 MG TABLET.
Who manufactures DEMECLOCYCLINE 300 MG TABLET?
DEMECLOCYCLINE 300 MG TABLET (NDC 24658071148) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.